Why the study?
What are the risk factors for death and reintervention following congenital mitral valve surgery?
What are the risk factors for death and reintervention following congenital mitral valve surgery?
Age <1 year, mitral valve dysplasia, and the need for mitral valve replacement are significant risk factors for death or reoperation in congenital mitral valve surgery, suggesting alternative strategies may be needed for symptomatic neonates with Shone's syndrome.
Answers are grounded in this paper and cite their sources.
Highlights elevated risks in infants with dysplasia or replacement; leaves open optimal strategies for congenital mitral surgery.
An age of <1 year, mitral valve dysplasia and a need for mitral valve replacement were associated with a higher incidence of death or reoperation. Primary mitral valve replacement or univentricular strategy may have to be considered for symptomatic neonates with Shone's syndrome.
No takes yet. Share an insight, caveat, or question.
Sughimoto et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: